Optimal risk factor modification and medical management of the patient with peripheral arterial disease
β Scribed by Yung-Wei Chi; Michael R. Jaff
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 269 KB
- Volume
- 71
- Category
- Article
- ISSN
- 1522-1946
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective To examine and compare risk factors for various stages of subclinical vascular disease in different vascular beds (carotid and aorta) in women with systemic lupus erythematosus (SLE) who have not yet developed clinical cardiovascular disease. ## Methods This crossβsectio
## Abstract Limited data are available regarding optimal treatment with desmopressin (DDAVP) or intermediateβpurity FVIII concentrates rich in VWF (CFCs) in patients with von Willebrand disease (VWD) who undergo planned surgery. We undertook a retrospective review over 10 years (1988β1997) and iden